ACTION Registry®–GWTG™ is a national, risk-adjusted, outcomes-based quality improvement program that helps participating facilities measure and improve care for high-risk ACS patients with STEMI and NSTEMI. The result of the collaboration between the two leading national coronary artery disease registries, the NCDR® ACTION Registry® and the American Heart Association (AHA) Get With The GuidelinesSM-CAD Registry, ACTION Registry–GWTG will be the largest, most comprehensive national cardiovascular patient database ever developed by the medical profession.
Combining the strengths of the two programs, ACTION Registry–GWTG will collect a comprehensive set of data elements that provide healthcare professionals and their facilities with the information they need to monitor and improve adherence to the most current, science-based ACC/AHA treatment guidelines. Participation will greatly facilitate quality improvement efforts, optimize clinical care, and improve clinical outcomes for acute coronary syndrome patients.
Visit How To Join to request additional information or to download an enrollment package. Or, visit the ACTION website for more information.
Miss EMCREG at ACEP 2009? The webcast if this event is now available online. This complimentary webcast includes CME for those who register before viewing.
ClinACS and ClinStroke are Palm OS handheld applications with an additional internet version compatible on any handheld and desktop, designed to help clinicians with the acute management of Stroke and Acute Coronary Syndrome. Both tools offer interactive features and are based on the recent 2007 guidelines from the American Heart Association. Download them today.
Stay in Touch with EMCREG events and educational materials:
NEWSFEED:
EMCREG is now "podcasting" all of our educational content including: Clinical update Newsletters [MP3 and PDF], webcasts, and monographs. Subscribe to our feeds an receive instant access to our educational materials.
E-MAIL SUBSCRIPTION:
Join Our Mailing List
NEW! ACEP 2008 MONOGRAPH: ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES
EMCREG–International is pleased to present this complimentary CME monograph covering the proceedings of our 2008 satellite symposium at the ACEP Scientific Assembly in Chicago, IL. The monograph covers the presented topics and provides up-to-date knowledge on the full spectrum of decision making and care for patients with acute coronary syndromes (ACS) including non-ST-segment elevation ACS (NSTE ACS) and ST-segment elevation myocardial infarction (STEMI), acute heart failure syndromes, pulmonary embolism, and acute ischemic stroke.
NEW! HYPERTENSIVE EMERGENCIES: ACUTE CARE EVALUATION AND MANAGEMENT
Hypertension remains one of the most common disease processes in patients presenting to the Emergency Department (ED). While
sometimes symptomatic and associated with end organ damage such as hypertensive encephalopathy, hemorrhagic stroke, acute coronary syndrome, heart failure, and renal insufficiency, many patients present without symptoms. Emergency physicians and hospitalists should understand the appropriate classification of patients with hypertension, the pathophysiology of this disease process, and appropriate treatment strategies. In this EMCREG-International Newsletter, Charles V. Pollack, Jr. MD
and Christopher J. Rees, MD of Pennsylvania Hospital and the University of Pennsylvania discuss hypertension and parenteral medications used for treatment of these patients in the ED.
THE EMCREG-INTERNATIONAL HYPERTENSION CONSENSUS PANEL: MANAGEMENT OF HYPERTENSIVE EMERGENCIES
The EMCREG-International Hypertension Consensus Panel gathered experts from diverse fields, including Emergency Medicine, Cardiology, Neurology, Neurosurgery, Neuro-Critical Care, Obstetrics/Gynecology, Nephrology, Pediatrics, and Hospital
Medicine to discuss, analyze, and provide recommendations for treating hypertension. Through this collaboration, virtually any patient presenting with hypertension to an outpatient or emergency department setting will have clear guidelines for treatment and physician follow-up.
ACEP 2007 MONOGRAPH: ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR, NEUROVASCULAR AND INFECTIOUS EMERGENCIES
EMCREG–International is pleased to present this complimentary 99-page CME monograph covering the proceedings of our 2007 satellite symposium at the ACEP Scientific Assembly in Seattle, Washington, Louisiana. A number of important topics are covered in this monograph including acute coronary syndrome, the diagnosis of transient ischemic attack and stroke, the treatment of ischemic and hemorrhagic stroke, the management of hypertension in acute neurovascular emergencies, the management of hypertensive urgencies and emergencies, markers for severe bacterial infections, the treatment of sepsis, risk stratification of possible acute coronary syndrome, the optimal management of NSTEMI and STEMI, treatment of acute heart failure syndrome, and the diagnosis and treatment of deep venous thrombosis and pulmonary embolism.
MANAGEMENT OF HYPERTENSION AND HYPERTENSIVE EMERGENCIES IN THE EMERGENCY DEPARTMENT: THE EMCREG-INTERNATIONAL CONSENSUS PANEL RECOMMENDATIONS
This supplement [Ann Emerg Med 2008;51(3 Suppl 1):S1-S38] represents the first supplement to Annals of Emergency Medicine in nearly 16 years! These consensus documents on the evaluation and management of hypertension and hypertensive emergencies in the ED was systematically developed between December 2006 and April 2007 in an evidence-based and consensus-based process and culminated in the March 2008 supplement of Annals. The panel members were
selected from a multidisciplinary group of specialists, which included physicians from emergency medicine, neurology, neurological surgery, internal medicine, hospital medicine, nephrology, cardiology, pediatrics, anesthesiology, vascular surgery, and gynecology and obstetrics. Each specific hypertension section or
topic was assigned at least 2 experts, one of whom was usually an emergency physician.
Relation Between Thrombolysis in Myocardial Infarction Risk Score and One-Year Outcomes for Patients Presenting at the Emergency Department With Potential Acute Coronary Syndrome
Weisenthal BM, Chang AM, Walsh KM, Collin MJ, Shofer FS, Hollander FE
Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
Levy PD, Nandyal D, Welch RD, Sun JL, Pieper K, Ghali JK, Fonarow GC, Gheorgiade M, O’Connor CM.
Intravenous Platelet Blockade with Cangrelor during PCI
Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW, Pollack CV, et al. for the CHAMPION PLATFORM Investigators
Results of the PLATO trial show that the reversible P2Y12 inhibitor ticagrelor reduces death and cardiovascular events compared with clopidogrel therapy in ACS patients.
Denmark researchers report in Lancet that relative risk for hospitalization for bleeding increased with all drug combinations and with each additional drug used.
Researchers report that the to reperfusion, beginning with symptom onset time, determines the extent of reversible myocardial injury in STEMI patients undergoing PCI.
Data presented at the AHA 2009 Scientific Sessions shows that dabigatran when added to dual anti-platelet therapy results in a “low and acceptable bleeding rate” in AMI patients.
Data presented at the AHA 2009 Scientific Sessions indicates that CT angiography in the emergency room can successfully triage at-risk chest-pain patients faster and cheaper than standard of care testing.
Recent meta-analysis reveals that high-risk STEMI patients given adjunctive glycoprotein (GP) IIb/IIIa inhibitor therapy and undergo primary angioplasty have a reduced risk for death.
